<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>A Multicenter Benchmark of Multiple Instance Learning Models for Lymphoma Subtyping from HE-stained Whole Slide Images - Health AI Hub</title>
    <meta name="description" content="This paper presents the first multicenter lymphoma subtyping benchmark dataset for deep learning, leveraging HE-stained whole slide images. It systematically ev">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>A Multicenter Benchmark of Multiple Instance Learning Models for Lymphoma Subtyping from HE-stained Whole Slide Images</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.14640v1" target="_blank">2512.14640v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-16
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Rao Muhammad Umer, Daniel Sens, Jonathan Noll, Christian Matek, Lukas Wolfseher, Rainer Spang, Ralf Huss, Johannes Raffler, Sarah Reinke, Wolfram Klapper, Katja Steiger, Kristina Schwamborn, Carsten Marr
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV, cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.14640v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.14640v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper presents the first multicenter lymphoma subtyping benchmark dataset for deep learning, leveraging HE-stained whole slide images. It systematically evaluates five pathology foundation models combined with two Multiple Instance Learning aggregators across various magnifications, achieving over 80% balanced accuracy on in-distribution data but revealing a substantial drop to around 60% on out-of-distribution sets, highlighting critical generalization challenges.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research aims to revolutionize lymphoma diagnosis by developing deep learning tools that can rapidly and accurately subtype lymphomas using only standard HE-stained slides, thereby potentially reducing diagnostic delays, lowering healthcare costs associated with extensive ancillary testing, and improving timely access to specific treatment regimens.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI application described is the development and benchmarking of deep learning models, specifically multiple instance learning (MIL) models combined with various pathology foundation models, to automatically subtype lymphoma from whole slide images (WSIs) of HE-stained tissue. This aims to assist pathologists in making faster and more accurate diagnoses, potentially reducing healthcare costs and treatment delays by providing diagnostic insights from readily available slides without requiring extensive additional tests like immunohistochemistry or flow cytometry.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>**Novel Multicenter Dataset**: The study introduces the first multicenter lymphoma benchmarking dataset comprising four common lymphoma subtypes and healthy control tissue from HE-stained whole slide images (WSIs).</li>
                    
                    <li>**Comprehensive Model Evaluation**: Five publicly available pathology foundation models (H-optimus-1, H0-mini, Virchow2, UNI2, Titan) were systematically evaluated, paired with attention-based (AB-MIL) and transformer-based (TransMIL) Multiple Instance Learning aggregators.</li>
                    
                    <li>**Magnification Optimization**: Models were assessed across 10x, 20x, and 40x magnifications, determining that 40x resolution is sufficient for optimal performance, with no additional gains from higher resolutions or cross-magnification aggregation.</li>
                    
                    <li>**Strong In-distribution Performance**: On in-distribution test sets, models achieved multiclass balanced accuracies exceeding 80%, with consistent performance across all evaluated foundation models and MIL aggregation methods.</li>
                    
                    <li>**Significant Generalization Gap**: A major finding was the substantial performance degradation to approximately 60% balanced accuracy on out-of-distribution test sets, underscoring significant challenges in model generalization across different institutions or data sources.</li>
                    
                    <li>**Potential Diagnostic Efficiency**: The research indicates that deep learning could potentially extract crucial diagnostic information directly from routinely available HE-stained slides, potentially streamlining the diagnostic process and reducing reliance on costly and time-consuming ancillary tests.</li>
                    
                    <li>**Facilitation of Future Research**: An automated benchmarking pipeline is provided by the authors to support and accelerate future, larger multicenter studies, particularly those aiming to include rarer lymphoma subtypes.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study involved constructing a novel multicenter dataset of HE-stained whole slide images for lymphoma subtyping. Five established pathology foundation models were integrated with two Multiple Instance Learning (MIL) aggregators (attention-based and transformer-based). These deep learning systems were then rigorously benchmarked across three different magnifications (10x, 20x, 40x) on both in-distribution and challenging out-of-distribution test sets, with performance primarily measured by multiclass balanced accuracy.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>Deep learning models demonstrated strong performance (>80% balanced accuracy) for lymphoma subtyping on in-distribution HE-stained WSI data. 40x magnification was determined to be optimal and sufficient. However, the models exhibited a significant vulnerability, with performance dropping substantially to approximately 60% balanced accuracy on out-of-distribution test sets, revealing a critical lack of generalization capability across unseen data sources.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>The findings suggest that deep learning holds significant promise for automating or assisting in the complex task of lymphoma subtyping, potentially enabling faster, more accessible, and more cost-effective diagnoses by reducing the need for extensive immunohistochemistry, flow cytometry, and molecular tests. While in-distribution performance is high, the generalization challenge must be robustly addressed before widespread clinical adoption to ensure reliable performance across diverse patient populations and institutions.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The most prominent limitation is the substantial drop in model performance observed on out-of-distribution test sets, indicating a critical lack of generalization across different data sources. Additionally, the multicenter dataset, while valuable, covers only four common lymphoma subtypes and healthy tissue, omitting the numerous rarer lymphoma variants.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Future research should focus on expanding the scope to include larger multicenter studies that encompass additional, particularly rarer, lymphoma subtypes to enhance the clinical utility and generalizability of deep learning models. The authors also facilitate this by providing an automated benchmarking pipeline for future research efforts.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pathology</span>
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Hematology</span>
                    
                    <span class="tag">Diagnostic Imaging (Digital Pathology)</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Lymphoma Subtyping</span>
                    
                    <span class="tag tag-keyword">Whole Slide Imaging (WSI)</span>
                    
                    <span class="tag tag-keyword">Deep Learning</span>
                    
                    <span class="tag tag-keyword">Multiple Instance Learning (MIL)</span>
                    
                    <span class="tag tag-keyword">Histopathology</span>
                    
                    <span class="tag tag-keyword">Multicenter Study</span>
                    
                    <span class="tag tag-keyword">Generalization</span>
                    
                    <span class="tag tag-keyword">Foundation Models</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Timely and accurate lymphoma diagnosis is essential for guiding cancer treatment. Standard diagnostic practice combines hematoxylin and eosin (HE)-stained whole slide images with immunohistochemistry, flow cytometry, and molecular genetic tests to determine lymphoma subtypes, a process requiring costly equipment, skilled personnel, and causing treatment delays. Deep learning methods could assist pathologists by extracting diagnostic information from routinely available HE-stained slides, yet comprehensive benchmarks for lymphoma subtyping on multicenter data are lacking. In this work, we present the first multicenter lymphoma benchmarking dataset covering four common lymphoma subtypes and healthy control tissue. We systematically evaluate five publicly available pathology foundation models (H-optimus-1, H0-mini, Virchow2, UNI2, Titan) combined with attention-based (AB-MIL) and transformer-based (TransMIL) multiple instance learning aggregators across three magnifications (10x, 20x, 40x). On in-distribution test sets, models achieve multiclass balanced accuracies exceeding 80% across all magnifications, with all foundation models performing similarly and both aggregation methods showing comparable results. The magnification study reveals that 40x resolution is sufficient, with no performance gains from higher resolutions or cross-magnification aggregation. However, on out-of-distribution test sets, performance drops substantially to around 60%, highlighting significant generalization challenges. To advance the field, larger multicenter studies covering additional rare lymphoma subtypes are needed. We provide an automated benchmarking pipeline to facilitate such future research.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>17 pages</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>